WCN26-2962 Telomere recapping via gene therapy as a therapeutic strategy for cardio-renal syndromes type 4

Read full text Summarise with VIRAT
Authors: Danshu Xie, Chenguang Wang, Xin Hua Wan, Longyu Wang, Yinlong Zhao, Jianan Pan, Jiaying Ji, Jiaolun Li, Feng Ding, Alex Chia Yu Chang, Wei Ding
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cardio-renal syndromes type 4 (CRS4) is defined as heart failure driven by chronic kidney disease (CKD). Cardiovascular mortality is the leading cause of mortality in advanced CKD patients. Current medical treatments exhibit limited efficacy. This study demonstrates that telomere shortening in cardiomyocytes is characteristic of CRS4.

Fields of Study & Subjects

Telomeres Telomerase and Senescence Mesenchymal stem cell research Cardiac Fibrosis and Remodeling

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104203–104203
Publication date
25 March 2026
Language
EN